Page last updated: 2024-12-05

2,4,6-tribromoanisole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2,4,6-Tribromoanisole is a brominated derivative of anisole. It has been synthesized via various methods, including the bromination of anisole using bromine in the presence of a Lewis acid catalyst, such as iron(III) bromide. This compound has been investigated for its potential biological activities, including its effects on the central nervous system and its antimicrobial properties. It is also used as an intermediate in the synthesis of other organic compounds. Research on 2,4,6-tribromoanisole is ongoing to explore its potential applications in different fields, such as pharmaceuticals, agrochemicals, and materials science.'
```

2,4,6-tribromoanisole: produced by O-methylation of its direct precursor, 2,4,6-tribromophenol, generally comes from sources in the winery environment [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11839
SCHEMBL ID301662
MeSH IDM0465116

Synonyms (44)

Synonym
do7m3m4lx5 ,
unii-do7m3m4lx5
methyl 2,4,6-tribromophenyl ether
hsdb 7814
ai3-00641
2,4,6-tba
nsc 2218
nsc-2218
nsc2218
607-99-8
benzene,3,5-tribromo-2-methoxy-
methyl 2,6-tribromophenyl ether
anisole,4,6-tribromo-
2,6-tribromoanisole
benzene, 1,3,5-tribromo-2-methoxy-
anisole, 2,4,6-tribromo-
2,4,6-tribromoanisole
2,4,6-tribromoanisole, 99%
T2301
AKOS000277640
1,3,5-tribromo-2-methoxybenzene
yxtrcoafnxqtkl-uhfffaoysa-
inchi=1/c7h5br3o/c1-11-7-5(9)2-4(8)3-6(7)10/h2-3h,1h3
A832891
1,3,5-tribromo-2-methoxy-benzene
FT-0632532
SCHEMBL301662
2,4,6-tribromoanisole [hsdb]
2,4,6-tribromoanisole [mi]
J-503844
DTXSID1060558
1219795-33-1
1,3,5-tribromo-2-methoxybenzene #
YXTRCOAFNXQTKL-UHFFFAOYSA-N
mfcd00192510
2,4,6-tribromoanisole, pestanal(r), analytical standard
2,4,6-tribromoanisole 10 microg/ml in isooctane
BBL102160
STL555959
Q4596770
PS-10191
D92594
2,4,6-tribromoanisole 1000 microg/ml in methanol
CS-0136295

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" The bioavailability of the liposomes was evaluated in rabbits, compared with the conventional self-emulsifying formulation for oral administration."( Preparation of liposomes containing zedoary turmeric oil using freeze-drying of liposomes via TBA/water cosolvent systems and evaluation of the bioavailability of the oil.
Fu, D; Yang, Z; Yu, S, 2010
)
0.36
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (23)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's13 (56.52)29.6817
2010's10 (43.48)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.54

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.54 (24.57)
Research Supply Index3.18 (2.92)
Research Growth Index4.38 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.54)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other23 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]